483
Hikma Farmaceutica, (Portugal) S.A.Hikma Farmaceutica, (Portugal) S.A. – FDA 483, Apr 21, 2023
Record Details
An FDA inspection of Hikma Farmaceutica, (Portugal) S.A., a sterile drug manufacturer, revealed significant deficiencies in their quality control and manufacturing processes. Observations included inadequate aseptic processing validation, failures in thoroughly investigating discrepancies and customer complaints, and issues with laboratory controls and stability testing. These findings indicate a lack of robust systems to ensure the quality and purity of sterile drug products.
View Company Profile
ID · 01ca53ba-9078-481a-b252-e92fcebc2e0d
Other documents for Hikma Farmaceutica, (Portugal) S.A.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.